2020

SEP

08

GlycoEra a business unit of LimmaTech Biologics will be attending the 20TH ANNUAL BIOTECH IN EUROPE FORUM from 21 through 24 September 2020.

AUG

19

GlycoEra a business unit of LimmaTech Biologics will be attending the Digital RESI from 14 through 16 September 2020.

AUG

19

GlycoEra a business unit of LimmaTech Biologics will be attending the virtual Antibody Engineering & Therapeutics Europe 2020 from 24 through 27 August 2020.

JUL

01

LimmaTech Biologics AG and University Hospital of Basel Receive Innosuisse Grant

Jun

01

LimmaTech & our CEO Veronica Gambillara Fonck featured in StartUp City Magazine: „An Alternate Way to Generate Therapeutic Proteins“

APR

30

LimmaTech Biologics will be attending the Digital RESI from 8 through 10 June 2020.

FEB

14

LimmaTech Biologics will be attending the RESI Europe in Paris on 23 March 2020.

JAN

29

LimmaTech Biologics will be attending the BIO-Europe Spring in Paris from 23 through 25 March 2020.

JAN

29

LimmaTech Biologics will be attending the 4th AMR Conference in Basel from 11 through 12 March 2020.

JAN

29

LimmaTech Biologics will be attending the Life Science Zurich Impact Conference in Zurich on 3 February 2020.

LimmaTech Biologics to present

JAN

29

LimmaTech Biologics will be attending the LSX World Congress in London from 4 through 5 February 2020.

JAN

29

LimmaTech Biologics will be attending the Keystone Symposia Antibodies as Drugs: From B Cell Biology to New Treatments in Santa Fe from 2 through 6 February 2020.

JAN

29

LimmaTech Biologics will be attending the SWISS NORDIC BIO 2020 Conference in Zurich on 6 February 2020.

LimmaTech Biologics to present

We use cookies to make this website work better for you and to track site visits anonymously. You can opt out if you like. ­Tell me more

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close